SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.75%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$289M
AUM Growth
+$289M
(-42%)
Cap. Flow
-$11.7M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
39.85%
Holding
261
New
44
Increased
40
Reduced
58
Closed
60
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.3M |
| 2 |
Abbott
ABT
|
$10.4M |
| 3 |
Outlook Therapeutics
OTLK
|
$7.04M |
| 4 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$5.95M |
| 5 |
SHPG
Shire pic
SHPG
|
$5.44M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 2 |
Plus Therapeutics
PSTV
|
$11.2M |
| 3 |
Biogen
BIIB
|
$6.55M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.88M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$2.84M |
Sector Composition
| 1 | Healthcare | 85.34% |
| 2 | Industrials | 0.77% |
| 3 | Consumer Staples | 0.45% |
| 4 | Consumer Discretionary | 0.43% |
| 5 | Technology | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Regeneron Pharmaceuticals
REGN
$61.5B
| $25M | 1.3% | 71,525 +32,498 | +83% | +$11.3M |
|
2
Amgen
AMGN
$155B
| $23.4M | 1.22% | 154,082 +10,596 | +7% | +$1.61M |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $14.9M | 0.78% | 783,497 +277,560 | +55% | +$5.29M |
|
|
4
Abbott
ABT
$231B
| $10.4M | 0.54% | +264,700 | New | +$10.4M |
|
|
5
Outlook Therapeutics
OTLK
$37.8M
| $7.04M | 0.37% | +2,068,968 | New | +$7.04M |
|
6
Tenax Therapeutics
TENX
$27.3M
| $6.67M | 0.35% | 2,606,035 -165,074 | -6% | -$423K |
|
|
BPTH
7
DELISTED
Bio-Path Holdings Inc
BPTH
| $5.95M | 0.31% | +2,988,295 | New | +$5.95M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $5.44M | 0.28% | +29,550 | New | +$5.44M |
|
|
PRTK
9
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.26M | 0.22% | 305,964 +113,642 | +59% | +$1.58M |
|
10
Dynavax Technologies
DVAX
$1.19B
| $4.24M | 0.22% | 290,505 +70,505 | +32% | +$1.03M |
|
|
GBT
11
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.21M | 0.22% | 254,029 +117,029 | +85% | +$1.94M |
|
12
Eledon Pharmaceuticals
ELDN
$155M
| $4.13M | 0.22% | 749,205 -62,995 | -8% | -$347K |
|
|
13
Plus Therapeutics
PSTV
$45.3M
| $4.11M | 0.21% | 1,966,708 -5,338,982 | -73% | -$11.2M |
|
14
Arbutus Biopharma
ABUS
$711M
| $4.09M | 0.21% | 1,176,031 -21,307 | -2% | -$74.2K |
|
15
CEL-SCI Corp
CVM
$71.8M
| $3.76M | 0.2% | +8,163,816 | New | +$3.75M |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.47M | 0.18% | 175,249 -84,394 | -33% | -$1.67M |
|
|
NVIV
17
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $3.35M | 0.18% | 580,343 +37,843 | +7% | +$219K |
|
18
Indaptus Therapeutics
INDP
$7.19M
| $3.35M | 0.17% | 743,545 +29,483 | +4% | +$133K |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.3M | 0.17% | 206,131 +93,947 | +84% | +$1.5M |
|
20
Regenxbio
RGNX
$451M
| $3.3M | 0.17% | 411,926 +111,597 | +37% | +$893K |
|
21
DURECT Corp
DRRX
$59.6M
| $3.1M | 0.16% | +2,540,278 | New | +$3.1M |
|
22
Iovance Biotherapeutics
IOVA
$807M
| $2.98M | 0.16% | 367,242 -45,004 | -11% | -$365K |
|
23
Precigen
PGEN
$1.34B
| $2.96M | 0.15% | 120,359 +8,452 | +8% | +$208K |
|
|
ALPN
24
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.95M | 0.15% | 641,492 -20,566 | -3% | -$94.6K |
|
25
Illumina
ILMN
$15.8B
| $2.81M | 0.15% | +20,000 | New | +$2.81M |
|